Altium Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,395,000	Closed	-$23.9M	–	25
2024 Q4	$23.9M	Buy	1,395,000 +35,000	+3%	+$658K	7.45%	1
2024 Q3	$27.2M	Sell	1,360,000 -150,000	-10%	-$2.33M	8.1%	2
2024 Q2	$16.9M	Sell	1,510,000 -30,000	-2%	-$252K	6.97%	2
2024 Q1	$10.2M	Buy	1,540,000 +445,000	+41%	+$2.43M	4.54%	6
2023 Q4	$4.95M	Sell	1,095,000 -1,628,011	-60%	-$6.02M	3.41%	13
2023 Q3	$9.75M	Buy	2,723,011 +343,011	+14%	+$1.32M	5.64%	7
2023 Q2	$8.78M	Sell	2,380,000 -490,000	-17%	-$1.82M	6.87%	4
2023 Q1	$9.5M	Hold	2,870,000	–	–	5.68%	3
2022 Q4	$11.1M	Sell	2,870,000 -13,710	-0.5%	-$42.3K	5.7%	2
2022 Q3	$7.01M	Sell	2,883,710 -1,116,290	-28%	-$2.68M	2.64%	5
2022 Q2	$7.92M	Buy	4,000,000 +700,000	+21%	+$1.38M	3.35%	3
2022 Q1	$6.04M	Hold	3,300,000	–	–	2.1%	11
2021 Q4	$4.65M	Buy	+3,300,000	New	+$4.34M	1.31%	28